clentiazem has been researched along with Body Weight in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwasaki, H; Kikkawa, K; Kurosawa, H; Murata, S; Nagao, T; Toriumi, W | 1 |
| Dolphin, PJ; Graham, SE; Russell, JC; Stewart, B | 1 |
| Billingham, ME; Bristow, MR; Deisher, TA; Fowler, MB; Ginsburg, R; Hoffman, BB; Narita, H; Zera, P | 1 |
| Blaise, G; Dumont, L; Jasmin, G; Tanguay, M | 1 |
| Fisher, M; Nunnari, JJ; White, SD | 1 |
| Banno, K; Iwasaki, H; Kikkawa, K; Murata, S; Nagao, T; Toriumi, W | 1 |
6 other study(ies) available for clentiazem and Body Weight
| Article | Year |
|---|---|
Effect of clentiazem (TA-3090) with posttreatment on neurologic and histologic disorders of stroke-prone spontaneously hypertensive rats with history of stroke.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Brain; Cerebrovascular Disorders; Diltiazem; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Kidney; Nervous System; Rats; Rats, Inbred SHR; Sodium, Dietary | 1994 |
Sexual dimorphism in the metabolic response to the calcium channel antagonists, diltiazem and clentiazem, by hyperlipidemic JCR:LA-cp rats.
Topics: Animals; Body Weight; Calcium Channel Blockers; Diltiazem; Female; Glucose; Hyperlipidemias; Insulin; Lipids; Lipoproteins; Male; Rats; Rats, Mutant Strains; Sex Factors | 1995 |
Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
Topics: Animals; Body Weight; Calcium Channel Blockers; Calcium Channels; Cardiomyopathies; Diltiazem; Endomyocardial Fibrosis; Epinephrine; Heart; Heart Ventricles; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1993 |
Coronary and cardiac sensitivity to the vasoselective benzothiazepine-like calcium antagonist, clentiazem, in experimental heart failure.
Topics: Animals; Body Weight; Calcium Channel Blockers; Chronic Disease; Coronary Vessels; Cricetinae; Cyclooxygenase Inhibitors; Diltiazem; Enzyme Inhibitors; Heart; Heart Failure; In Vitro Techniques; Indomethacin; Mesocricetus; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase | 1997 |
Inhibition of lipid deposition in the hypercholesterolemic rat by clentiazem, a calcium channel blocker.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Calcium Channel Blockers; Cell Adhesion; Cell Count; Cholesterol; Cholic Acids; Diet, Atherogenic; Diltiazem; Heart Rate; Hypercholesterolemia; Lipid Metabolism; Lipids; Male; Models, Biological; Monocytes; Rats; Rats, Wistar; Thiouracil | 1992 |
Prophylactic effects of a new 1,5-benzothiazepine calcium antagonist on stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Cerebral Cortex; Cerebrovascular Disorders; Circadian Rhythm; Diltiazem; Eating; Hypertension; Kidney Cortex; Male; Rats; Rats, Inbred SHR; Sodium Chloride | 1992 |